Health, Vaccines, Lyme Disease, FDA, Medicine.
associated with purported autoimmune reactions, notes Valneva Chief Executive Officer Thomas Lingelbach. Instead, the researchers combined portions of different epitopes to target a variety of Borrelia strains. Lingelbach makes a point of noting that LYMErix was proven to be safe. Nevertheless,